Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Aug 2024 for Gain Therapeutics, Inc., €13k.
Filing timeline
BuySaleGene Mack
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +65.6%Entry US$0.94 · Close at T+365 US$1.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gene Mack: trading record in brief
Our data holds just one disclosure by Gene Mack, dated 12 August 2024, reporting an open-market purchase worth €13k in Gain Therapeutics, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gene Mack
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 14,400 shares@ US$1.01100.0% of flowCommon StockSEC:0001493152-24-031378:0Canonical exit: 7 Nov 2024 (T+90)
1 of 1 declaration